← Dashboard🔄 Claude update
BA
The Boeing Company
NYSE · Aerospace & Defense · Commercial Aircraft + Defense + Services
Price (Nov 6, 2026)
$173.40
Mkt Cap ~$135B · Turnaround play — recovery or value trap?
50% HOLD
📅 Last updated: Nov 6, 2026
Market Cap
~$135B
P/E (Trailing)
N/M (loss)
P/E (Forward)
~40-50x
Revenue (TTM)
~$95B
Div Yield
0%
Next Earnings
Jan 27, 2027 (est.)
PennyCheck™
50% HOLD
Business Quality & Situation

Boeing is the world's second-largest commercial aircraft manufacturer (after Airbus) and America's largest defense contractor. The business has three segments: Commercial Airplanes (737, 767, 777, 787), Defense Space & Security (F/A-18, KC-46, 747, Chinook, plus the new F/A-XX fighter), and Global Services (maintenance, parts, training). The company has endured a catastrophic 2019–2025 period: the 737 MAX grounding, two fatal crashes, COVID demand collapse, IAM machinists' strike, and ongoing manufacturing quality issues that resulted in an FAA production cap on the 737 MAX.

Q3 2026 represents a potential inflection: revenue of $24.2B (+4% YoY), operating income of $354M (vs. -$4.8B loss a year prior), positive operating cash flow of $1.5B, and 161 deliveries with 300 net orders. The backlog has reached a record $745B. For the first time in years, Boeing looks like it might be on the right path — but the debt load ($45.9B) against $20.7B cash, and an $116M net loss, remind us this is still a company in recovery, not one that has recovered.

Mispricing Diagnosis

Bull argument: Boeing is a duopoly with $745B in backlog, record defense contracts (F/A-XX program win), and a Services segment generating 18%+ margins. At peak normalized earnings ($15–20 EPS), the stock trades at 9-12x — cheap for a defense/aerospace duopolist. If Boeing reaches Airbus-like operating margins (8-10%), intrinsic value is $300-400+.

Bear argument: Boeing's execution has been so poor for so long that "peak normalized earnings" is fiction. The FAA production cap, ongoing 737 quality issues, and massive debt burden could prevent Boeing from ever reaching those margins. The company may need another equity raise — diluting current shareholders. Airbus is gaining market share in every segment Boeing is weak.

Verdict on mispricing: This is a genuine turnaround bet, not a classic mispricing. The asymmetry only works if you believe management can execute — which is a large leap of faith given recent history. Not a thesis-driven mispricing; more of a cyclical/operational recovery bet.

Q3 2026 Financial Snapshot
Q3 Revenue
$24.2B
+4% YoY
Q3 Net Loss
-$116M
-$0.26/share; much smaller than -$5.3B Q3'25
Operating Income
$354M
vs. -$4.8B operating loss YoY
Operating Cash Flow
$1.5B
First positive OCF in 6+ quarters
Total Backlog
$745B
Record high
Deliveries
161
Commercial; 300 net orders
Balance Sheet & Capital Structure
  • Debt: $45.9B total — elevated from COVID-era borrowing + strike impacts + operational losses. Net debt ~$25B after cash.
  • Cash: $20.7B in cash and marketable securities — adequate near-term liquidity but not comfortable.
  • Dividend: Suspended since 2020 — no near-term reinstatement likely given cash burn history.
  • Defense segment margin: 6.2% (Q3 2026) — defense is cash-constrained due to fixed-price contracts gone wrong (KC-46, Air Force One).
  • Services segment margin: 18.3% — the hidden gem. High-margin, recurring, and growing as the installed base ages.
  • Certification milestones: 737-7 and 737-10 pending FAA certification — when these clear, production can ramp and cash flow improves materially.
Competitive Position
  • Duopoly market structure: Airbus and Boeing together control ~95% of large commercial aircraft sales. No credible new entrant (COMAC is decades from credible Western competition). The addressable market is captive to two players.
  • $745B backlog: Even if Boeing delivers zero new orders for years, it has a decade+ of work in hand. The backlog is sticky because airline planning cycles are 5-10 years long.
  • Defense incumbency: F/A-XX program win (US Navy's next-generation fighter) locks Boeing into decades of defense revenue. No competitor can unseat an incumbent on critical national security programs.
  • Services flywheel: As the global Boeing fleet ages, aftermarket services (parts, maintenance, training) grow automatically. This is the most durable moat segment.
  • Key risk to moat: Airbus is winning market share. The A321XLR competes head-on with Boeing's 737 MAX and there is no Boeing response product. If this continues 5-10 years, Boeing's commercial market share erodes from ~45% to ~35% or below — weakening the duopoly thesis.
Key Risks & Asymmetry Killers
HIGH
Execution failure on ramp-upBoeing has repeatedly promised production ramp-ups that failed due to quality issues, supplier problems, or regulatory holds. If the 737 MAX hits another quality problem or the FAA imposes another production cap, the entire recovery thesis unravels.
HIGH
Equity dilution riskBoeing's $45.9B debt at current negative/near-zero operating cash flow could force another equity raise if conditions deteriorate. The 2024 equity raise diluted shareholders significantly — another one would be damaging.
HIGH
Fixed-price defense contract lossesSeveral major defense programs (KC-46 tanker, Air Force One) have cost Boeing billions in fixed-price losses. New program wins (F/A-XX) could repeat this pattern if costs overrun.
MED
Airbus market share gainEvery year Boeing struggles, Airbus takes more of the single-aisle and wide-body market. This is a slow bleed, not a crisis, but it compounds over time and reduces Boeing's long-run earnings power.
MED
737-7 and 737-10 certification delayThese MAX variants have been in certification for years. Further delays push out cash flow recovery and customer order bookings.
Binary Catalysts
  • 737-7 and 737-10 FAA certification (2026-2027): When granted, production rate can accelerate from ~38/month toward 50-52/month. Each unit = ~$55-65M revenue. This is the single most important near-term catalyst.
  • Q4 2026 earnings (Jan 2027): Will Boeing show consecutive quarters of positive operating cash flow? A second positive OCF quarter would be highly significant for the recovery narrative.
  • Defense contract performance: Any update on F/A-XX program margin expectations (cost-plus vs. fixed price structure) would move the stock significantly.
  • Potential Airbus partnership or asset sale: Speculative, but if Boeing were to exit certain non-core programs or partner with a defense prime, it could crystallize asset value.
  • Strike or labor disruption (downside catalyst): The IAM strike in 2025 cost Boeing ~$6B in losses. Any renewed labor action is an immediate asymmetry killer.
PennyCheck™ Scorecard
Business Model Quality
4/5
Revenue Quality & Growth
3/5
Competitive Moat
4/5
Management & Execution
1/5
Balance Sheet Health
1/5
Sector Tailwinds
4/5
Valuation vs. Intrinsic
3/5
Near-Term Catalysts
3/5
Intrinsic Value Scenarios
ScenarioTarget PriceKey AssumptionTimeframeLikelihood
Bear$80Another quality crisis, FAA production cap renewal, equity dilution; 0.8x revenues12–24 mo25%
Base$220Gradual recovery to 38→50/mo 737, $6–8 EPS by 2028, 28x peak earnings24–36 mo50%
Bull$380Full recovery to Airbus-like 10% margins; $15 EPS; 25x on normalized earnings36–60 mo25%
Asymmetry Scorecard

Bear case: $80 from $173.40 = -53.8%
Bull case: $380 from $173.40 = +119.2%
Weighted-average: (50% × +$47) + (25% × +$207) = $75 upside vs (25% × -$93) = $23 downside → ~3.2:1

The ratio clears 2:1 — but this analysis is fragile. The bear case probability is 25% and represents devastating downside (-54%). This is not a defensive asymmetric opportunity; it's a turnaround bet where the base case requires 2-3 years of patience. The asymmetry improves significantly if you buy closer to $140.

Position Sizing Signal

🟡 Tier 2 — Starter Position Only, Add on Weakness

Boeing is a classic "fallen giant" with structural moats and genuine recovery potential, but execution risk is severe. The 25% bear case (-54%) is not tail risk — it's a plausible outcome given Boeing's execution history. At $173, the asymmetry is marginal. Ideal entry is $130-$150 where the asymmetry improves to 4-5:1. If Boeing delivers two consecutive quarters of FCF positive, the thesis strengthens materially. For now: starter position, tight sizing, monitor 737 certification timeline.

58%
HOLD · 23/40 · PennyCheck™
Verdict

Thesis: Boeing's structural duopoly moat and $745B backlog guarantee long-term relevance, but management has an execution credibility problem severe enough to discount near-term recovery promises heavily.

Mispricing: Partial — market may undervalue the Services segment (18% margins) and the genuine defense franchise. But the bear case is real and large. This is not a classic "cheap and overlooked" situation.

Asymmetry: ~3.2:1 — passes threshold but requires multi-year patience and tolerates 54% drawdown in bear case.

Buy price: $130–$150 for sizing up. At $173, starter position only.

Tier: 2 — Watchlist / starter, add if 737-7 certified and positive FCF sustained.

Update Log
🔄 Add an update with ClaudeAfter earnings or news: opens Claude with this ticker pre-filled; the new entry appears here a few minutes after it finishes.
No updates yet — check back after next earnings or a material news event.